{
  "source": "Global Wire",
  "source_name": "Global Wire",
  "meta_source_name": "Global Wire",
  "source_guid": "src-global-wire",
  "trust_level": 10,
  "source_type": "NEWS_WIRE",
  "group_guid": "group-simulation",
  "event_type": "OTHER",
  "published_at": "2026-02-22T11:48:10.249836",
  "upload_as_group": "group-simulation",
  "title": "Update regarding Vitality Pharma",
  "story_body": "Vitality Pharma Corporation, a pharmaceutical company, announced the appointment of Dr. Maria Rodriguez as Director of Clinical Research, effective immediately.\n\nAccording to a filing with the Securities and Exchange Commission on 2023-02-15 08:00:00 EST, Dr. Rodriguez will oversee the development and implementation of clinical trials for the company's pipeline of products.\n\nIn marketing news, Vitality Pharma Corporation launched a revised website on 2023-02-10, featuring updated product information and enhanced navigation.\n\nIn Environmental, Social, and Governance (ESG) news, Vitality Pharma Corporation reported that it has reduced its greenhouse gas emissions by 2% in the fourth quarter of 2022 compared to the same period in 2021.\n\nThe company also announced that it has achieved a 95% recycling rate for its office facilities in 2022.\n\nNo further information was provided by Vitality Pharma Corporation regarding these updates.",
  "validation_metadata": {
    "scenario": "Standard Filler",
    "base_ticker": "VIT",
    "expected_tier": "STANDARD",
    "expected_event": "OTHER",
    "expected_relevant_clients": [
      "550e8400-e29b-41d4-a716-446655440001",
      "550e8400-e29b-41d4-a716-446655440005"
    ],
    "relationship_hops": 0,
    "expected_feed_rank_range": "1-50",
    "validation_rules": {
      "min_score": 0,
      "max_score": 49,
      "expected_tier": "STANDARD",
      "must_match_event": false,
      "expected_event": "OTHER",
      "expected_entities": [],
      "expected_relevant_clients": [],
      "relationship_hops": 0,
      "expected_feed_rank_range": "1-50"
    }
  }
}